Search results for: 'research area dna damage atm kinase'
-
A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor
-
A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve
-
A8412 Dinaciclib (SCH727965)2 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK inhibitor
-
A8245 Sorafenib Tosylate1 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
-
A1805 Imatinib Mesylate (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor
-
B1399 TemozolomideSummary: DNA methylating, chemotherapeutic agent
-
A5719 AT7519Target: Cyclin-Dependent KinasesSummary: Multi-CDK inhibitor
-
A1980 SNS-032 (BMS-387032)2 CitationTarget: Cyclin-Dependent KinasesSummary: CDK inhibitor
-
A8642 R5472 CitationTarget: Cyclin-Dependent KinasesSummary: CDK1/2/4 inhibitor,ATP-competitive
-
A1906 Decitabine (NSC127716, 5AZA-CdR)Summary: Deoxycytidine analog and cellular diifferentiation inducer